![](https://wthumb.tpgimages.com/mid2_com_img/1339/31887/TPG35116111.jpg)
Illustration of adalimumab (orange) binding the cytokine tumour necrosis factor-alpha (TNF-a, blue). Adalimumab is a therapeutic monoclonal antibody used to bind excess TNF-a in the body, overproduction of which causes inflammation, swelling, and pain. It is used for the treatment of autoimmune diseases such as rheumatoid and psoriatic arthritis, Crohns disease and ulcerative colitis.
px | px | dpi | = | cm | x | cm | = | MB |
Details
Creative#:
TPG35116111
Source:
達志影像
Authorization Type:
RF
Release Information:
須由TPG 完整授權
Model Release:
N/A
Property Release:
N/A
Right to Privacy:
No
Same folder images:
3dadalimumabalphaantitnf-aanti-tnf-aantibodyartworkautoimmunediseasebindingbiochemicalbiochemistrybiologicalbiologyboundcgicytokinedigitallygenerateddruggraybackgroundgreybackgroundhealthcarehumiraillustrationimmunesystemimmunologicalimmunologymedicalmedicationmedicinemolecularmolecularstructuremoleculemoleculesmonoclonalno-onenobodypharmaceuticpharmaceuticalpharmacologicalpharmacologyprescriptiondrugproteinsignalproteintherapythreedimensionaltreatingtreatmenttumournecrosisfactortumournecrosisfactor-alpha
3dadalimumabalphaantianti-tnf-aantibodyartworkautoimmunebackgroundbackgroundbindingbiochemicalbiochemistrybiologicalbiologyboundcgicytokinedigitallydimensionaldiseasedrugdrugfactorfactor-alphageneratedgraygreyhealthcarehumiraillustrationimmuneimmunologicalimmunologymedicalmedicationmedicinemolecularmolecularmoleculemoleculesmonoclonalnecrosisnecrosisno-onenobodypharmaceuticpharmaceuticalpharmacologicalpharmacologyprescriptionproteinproteinsignalstructuresystemtherapythreetnf-atreatingtreatmenttumourtumour